Notably, patients with MASLD had different serum kinetics of IL-6, IL-10, IL-23, IL-33, TGF-β1 and IFN-γ, as well as of chemokines CXCL10, CCL11, CCL17, CCL20 and CXCL1. This evidence concerns the gene CXCL1 and metabolic dysfunction-associated steatotic liver disease.